News
DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for DaVita HealthCare (DVA). Shares have added about 13% in that time frame, outperforming the S&P 500.
But investors have to be wondering
Why Is Disney (DIS) Down 0.9% Since Last Earnings Report?
A month has gone by since the last earnings report for Walt Disney (DIS). Shares have lost about 0.9% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the
Healthpeak (DOC) Up 6.3% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Healthpeak (DOC). Shares have added about 6.3% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue
Ashland (ASH) Down 2.4% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Ashland (ASH). Shares have lost about 2.4% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent
APTIV HLDS LTD (APTV) Down 8.7% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Aptiv PLC (APTV). Shares have lost about 8.7% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the
Budget iPhone 17e to Boost Apple Revenues? ETFs to Consider
The iPhone had a record-breaking fiscal first quarter of 2026, driven by exceptional demand and all-time high sales across all geographic regions, as highlighted by CEO Tim Cook in the company’s
Viking Q4 Earnings & Revenues Surpass Estimates, Improve Y/Y
Viking Holdings (VIK) reported better-than-expected fourth-quarter 2025 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate and improved on a year-over-year basis.
ThredUp Q4 Earnings In Line With Estimates, Revenues Up 18% Y/Y
ThredUp Inc. TDUP reported fourth-quarter 2025 results, wherein both the top and bottom lines increased year over year. The company’s earnings came in line with the Zacks Consensus Estimate and
Old Dominion Unveils Weak LTL Unit Performance for February
Old Dominion Freight Line, Inc. (ODFL) has provided an update on the performance of its less-than-truckload (LTL) segment, which is its primary revenue generator, for February.
Old Dominion's
Sally Beauty's Color Sales Rise 8%: Is the Growth Sustainable?
Sally Beauty Holdings, Inc. SBH delivered a strong performance in its core color category, along with continued momentum from its licensed Colors on Demand (LCOD) platform. The color category saw
4 Consumer Product Stocks Set to Benefit From Strong Industry Momentum
Ryanair's Traffic Numbers for February 2026 Improve Year Over Year
Ryanair Holdings RYAAY, a European carrier, reported solid traffic numbers for February 2026, driven by upbeat air-travel demand.
The number of passengers transported on Ryanair flights was 13.3
Bayer Q4 Earnings Match Estimates, Xarelto and Eylea Pull Down Sales
Bayer AG BAYRY reported fourth-quarter 2025 core earnings of 18 cents per American Depositary Receipt (ADR), in line with the Zacks Consensus Estimate. The company reported earnings of 28 cents per
Tesla’s 2026 May Hinge on a March 9 Outcome
Shares of Tesla Inc (NASDAQ: TSLA) are trading right around $390, back at the bottom of a multi-month range after repeatedly failing to build on January’s earnings beat. The company topped
ADP Reports Highest New Job Postings Since Last July
Pre-market indexes are pushing higher this morning, bolstered somewhat by a not-disappointing private-sector employment report and fighting heroically off -2% levels during yesterday’s trading
Caterpillar Trades at Premium Valuation: How to Play the Stock?
Caterpillar Inc. CAT stock is currently trading at a forward price-to-sales ratio of 4.50, above the manufacturing - construction and mining industry’s 3.47. With a Value Score of D, CAT stock does
Apple Expands Mac Portfolio With New Devices: Can They Revive Growth?
Apple AAPL is expanding its Mac portfolio with the launch of MacBook Air and MacBook Pro. The devices come at an opportune time as the iPhone maker faces stiff competition from the likes of Lenovo
Gross Bookings Growth Bodes Well for Uber: What's Ahead?
Uber Technologies UBER, the San Francisco-based ride-hailing giant, continues to benefit from robust growth in gross bookings, reflecting strong and sustained demand across its platform. The company
Stryker Unveils Next-Gen Orthopedic Innovations at AAOS 2026
Stryker SYK recently introduced the latest additions to its Triathlon Total Knee System, expanded its Mako SmartRobotics platform and advanced its power tools portfolio. The company highlighted its
FN Jumps 25% in a Month: Is There More Room for the Stock to Grow?
Fabrinet FN shares have jumped 24.9% in a month, driven by an accelerating Telecom and Datacenter Interconnect (DCI) revenues, easing datacom constraints and continued scaling in High-Performance
TREE Lags Q4 Earnings Estimates, Stock Up 23.9% on Revenue Growth
LendingTree, Inc.TREE reported fourth-quarter 2025 adjusted net loss per share of 39 cents against the Zacks Consensus Estimate of earnings of 90 cents and the year-ago adjusted net income of $1.16
B&G Foods Q4 Earnings Meet Estimates, Sales Decrease 2.2% Y/Y
B&G Foods, Inc. BGS posted fourth-quarter 2025 results, wherein the bottom line came in line with the Zacks Consensus Estimate, but declined year over year. The top line was pressured by recent
Implied Volatility Surging for South Plains Financial Stock Options
Investors in South Plains Financial, Inc. SPFI need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $22.50 Put had some of the
Sea Limited Q4 Earnings Miss Estimates, Revenues Increase Y/Y
Sea Limited SE reported adjusted earnings of 80 cents per share in the fourth quarter of 2025, which increased 29% from the year-ago quarter but missed the Zacks Consensus Estimate by
ESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75M
Esperion Therapeutics ESPR announced that it has entered into a definitive agreement to acquire Nevada-based, privately held, commercial-stage biopharmaceutical company, Corstasis Therapeutics, for


